Regeneron Announces Upcoming 2013 Investor Conference Presentations
TARRYTOWN, N.Y., Feb. 19, 2013
TARRYTOWN,N.Y., Feb. 19, 2013 /PRNewswire/ --Regeneron Pharmaceuticals, Inc.
(NASDAQ: REGN) will webcast management presentations at the following investor
oCiti 2013 Global Healthcare Conference; Dyslipidemia Panel on Tuesday,
February 26, 2013. The session is scheduled for 1:30 p.m. Eastern Time.
oRBC Capital Markets' 2013 Global Healthcare Conference on Wednesday,
February 27, 2013. The presentation is scheduled for 9:30 a.m. Eastern
oBarclays Global Healthcare Conference on Tuesday, March 12, 2013. The
presentation is scheduled for 2:30 p.m. Eastern Time.
The sessions may be accessed through the Company's web site,
www.regeneron.com, on the 'Events and Presentations' page. An archived
version of the presentations will be available for 30 days.
About Regeneron Pharmaceuticals, Inc.
Regeneron is a leading science-based biopharmaceutical company based in
Tarrytown, New York that discovers, invents, develops, manufactures, and
commercializes medicines for the treatment of serious medical conditions.
Regeneron markets medicines for eye diseases, colorectal cancer, and a rare
inflammatory condition and has product candidates in development in other
areas of high unmet medical need, including hypercholesterolemia, rheumatoid
arthritis, and asthma. For additional information about the company, please
Michael Aberman, M.D. Peter Dworkin
Investor Relations Corporate
SOURCE Regeneron Pharmaceuticals, Inc.
Press spacebar to pause and continue. Press esc to stop.